Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
JANUX THERAPEUTICS INC
About JANX
Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. It has developed three bispecific platforms: Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM). Its TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain. Its TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain. Its clinical candidates include JANX007 and JANX008. JANX007 is a prostate-specific membrane antigen (PSMA-TRACTr) designed to target PSMA, a protein expressed in prostate cancer tumors and the vasculature of other tumors. JANX008 is an epidermal growth factor receptor (EGFR-TRACTr), being studied for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and others.
Find out what a historical investment in JANUX THERAPEUTICS INC would be worth today using our JANX stock calculator.
Market Capitalisation
$847.07M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
737.32K
High today
$14.40
Low today
$13.63
Open price
$14.30
52-week high
$35.34
52-week low
$12.12
Ready to start your investing journey with Stake?
Open an accountHow do I buy JANX shares in Australia?
Buying JANX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in JANUX THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in JANX
What is the ticker symbol of JANUX THERAPEUTICS INC?
The ticker symbol for JANUX THERAPEUTICS INC is JANX.
How much is one share of JANX?
One share of JANX is valued at $13.86 as of 16 May 2026.
What is the market capitalisation of JANUX THERAPEUTICS INC JANX?
As of 16 May 2026 JANUX THERAPEUTICS INC has a market cap of $847.07M.
What is the 52-week high for JANUX THERAPEUTICS INC stock?
The JANUX THERAPEUTICS INC 52-week high stock price is $35.34.
What is the 52-week low for JANUX THERAPEUTICS INC stock?
The JANUX THERAPEUTICS INC 52-week low stock price is $12.12.
Can I buy JANX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy JANX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in JANX on Stake
- Buy JANX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of JANX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
JANX related stocks